Organovo’s chief scientific officer, Sharon Presnell, will resign next week, according to a regulatory document the company filed Tuesday. Presnell is also president of Organovo subsidiary Samsara Sciences.
Organovo (NASDAQ: [[ticker:ONVO]]) is using what it calls 3D bio-printing technology to make living human liver tissue “patches”; Samsara sells human liver cells for research applications.
Presnell’s resignation will be effective Dec. 5. She is relocating to the East Coast to join a nonprofit and to be closer to family, Organovo said in the filing.
Author: Sarah de Crescenzo
Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register.
She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine.
View all posts by Sarah de Crescenzo
